Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
   PubMed Web of Science ®Google Scholar
• Chen WJ, Gan TQ, Qin H, et al. Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma. Pathol Res Pract. 2017;213:364–372.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research, N. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012;489:519–525.
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299–311.
   PubMed Web of Science ®Google Scholar
• Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Rev Clin Oncol. 2008;5:588–599.
   Web of Science ®Google Scholar
• Lin C, Yang L. Long noncoding RNA in cancer: wiring signaling circuitry. Trends Cell Biol. 2018;28:287–301.
   PubMed Web of Science ®Google Scholar
• Heery R, Finn SP, Cuffe S, et al. Long non-coding RNAs: key regulators of epithelial-mesenchymal transition, tumour drug resistance and cancer stem cells. Cancers (Basel). 2017;9:38.
   PubMed Web of Science ®Google Scholar
• Ning P, Wu Z, Hu A, et al. Integrated genomic analyses of lung squamous cell carcinoma for identification of a possible competitive endogenous RNA network by means of TCGA datasets. PeerJ. 2018;6:e4254.
   PubMed Web of Science ®Google Scholar
• Song J, Ye A, Jiang E, et al. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC. J Cell Biochem. 2018;119:6665–6673.
   PubMed Web of Science ®Google Scholar
• Li-Li Zhao B-R. Identification of potential prognostic ceRNA module biomarkers in patients with pancreatic adenocarcinoma. Oncotarget. 2017;8:94493–94504.
   PubMedGoogle Scholar
• Zhao G, Fu Y, Su Z, et al. How long non-coding RNAs and microRNAs mediate the endogenous RNA network of head and neck squamous cell carcinoma: a comprehensive analysis. Cell Physiol Biochem. 2018;50:332–341.
   PubMedGoogle Scholar
• Fan CN, Ma L, Liu N. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. J Transl Med. 2018;16:264.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Qian W, Wang S, et al. Analysis of lncRNA-associated ceRNA network reveals potential lncRNA biomarkers in human colon adenocarcinoma. Cell Physiol Biochem. 2018;49:1778–1791.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang C, He W, et al. Construction and comprehensive analysis of dysregulated long non-coding RNA-associated competing endogenous RNA network in clear cell renal cell carcinoma. J Cell Biochem. 2018. 1–18. DOI:10.1002/jcb.27557
   Web of Science ®Google Scholar
• Wang X, Han L, Zhou L, et al. Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network. Oncol Rep. 2018;40:2659–2673.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hou J, He D, et al. The emerging function and mechanism of ceRNAs in cancer. Trends Genet. 2016;32:211–224.
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505:344–352.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353–358.
   PubMed Web of Science ®Google Scholar
• Rokavec M, Horst D, Hermeking H. Cellular model of colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs, and epigenetic modifications associated with metastasis. Cancer Res. 2017;77:1854.
   PubMed Web of Science ®Google Scholar
• Chou C-H, Chang N-W, Shrestha S, et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res. 2016;44:D239–D247.
   PubMed Web of Science ®Google Scholar
• Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2015;43:D146–D152.
   PubMed Web of Science ®Google Scholar
• Fromm B, Billipp T, Peck LE, et al. A uniform system for the annotation of vertebrate microRNA genes and the evolution of the human microRNAome. Annu Rev Genet. 2015;49:213–242.
   PubMed Web of Science ®Google Scholar
• Shi X, Sun M, Liu H, et al. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339:159–166.
   PubMed Web of Science ®Google Scholar
• Dey BK, Mueller AC, Dutta A. Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription. 2014;5:e944014.
   PubMedGoogle Scholar
• Rui Xue Tang W-J, He R-Q, Zeng J-H, et al. Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma. Oncotarget. 2017;8:50761–50773.
   PubMedGoogle Scholar
• Sui J, Xu S-Y, S-RY JH, et al. Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic bimarkers in human lung squamous cell carcinoma. Oncotarget. 2017;8:65997–66018.
   PubMedGoogle Scholar
• Shao-ping Zhu J-Y, Wang X-G, Zhao J-P. Long intergenic non-protein coding RNA 00858 functions as a competing endogenous RNA for miR-422a to faciliate the cell growth in non-small cell lung cancer. Aging. 2017;9:475–486.
   PubMedGoogle Scholar
• Li C, Wan L, Liu Z, et al. Long non-coding RNA XIST promotes TGF-beta-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer. Cancer Lett. 2018;418:185–195.
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhang H, Hu X, et al. Knockdown of long non-coding RNA XIST inhibits cell viability and invasion by regulating miR-137/PXN axis in non-small cell lung cancer. Int J Biol Macromol. 2018;111:623–631.
   PubMed Web of Science ®Google Scholar
• Tang LX, Chen GH, Li H, et al. Long non-coding RNA OGFRP1 regulates LYPD3 expression by sponging miR-124-3p and promotes non-small cell lung cancer progression. Biochem Biophys Res Commun. 2018;505:578–585.
   PubMed Web of Science ®Google Scholar
• Liang R, Xiao G, Wang M, et al. SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma. Biomed Pharmacother. 2018;107:1434–1446.
   PubMed Web of Science ®Google Scholar
• Wu DM, Wang S, Wen X, et al. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma. Cell Death Dis. 2018;9:947.
   PubMed Web of Science ®Google Scholar
• Zhang W, Huang C, Gong Z, et al. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Hist. 2013;44:545–554.
   PubMed Web of Science ®Google Scholar
• Chen J, Hu L, Wang J, et al. Low expression LncRNA TUBA4B is a poor predictor of prognosis and regulates cell proliferation in non-small cell lung cancer. Pathol Oncol Res. 2017;23:265–270.
   PubMed Web of Science ®Google Scholar
• He J, Wu K, Guo C, et al. Long non-coding RNA AFAP1-AS1 plays an oncogenic role in promoting cell migration in non-small cell lung cancer. Cell Mol Life Sci. 2018;75:4667–4681.
   PubMed Web of Science ®Google Scholar
• Zhang HY, Yang W, Zheng FS, et al. Long non-coding RNA SNHG1 regulates zinc finger E-box binding homeobox 1 expression by interacting with TAp63 and promotes cell metastasis and invasion in lung squamous cell carcinoma. Biomed Pharmacother. 2017;90:650–658.
   PubMed Web of Science ®Google Scholar
• Cui F-mZ Y, Zhu C-K, Geng L, et al. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/B-catenin signaling pathway. Oncotarget. 2017;8:17785–17794.
   PubMedGoogle Scholar
• Yao J, Zhou B, Zhang J, et al. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells. Tumor Biol. 2014;35:7935–7944.
   PubMedGoogle Scholar
• Li Q, Dai Y, Wang F, et al. Differentially expressed long non-coding RNAs and the prognostic potential in colorectal cancer. Neoplasma. 2016;63:977–983.
   PubMed Web of Science ®Google Scholar
• Cao B, Liu C, Yang G. Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway. Biomed Pharmacother. 2018;107:185–193.
   PubMed Web of Science ®Google Scholar
• Wang A, Jin C, Li H, et al. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway. Int J Biol Macromol 2018;120:1705–1713.
   PubMed Web of Science ®Google Scholar
• Liu C, Yang Z, Deng Z, et al. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3. IUBMB Life. 2018;70:536–546.
   PubMed Web of Science ®Google Scholar
• Hong-Yuan W, Xiao-Ping C. miR-338-3p suppresses epithelial-mesenchymal transition and metastasis in human nonsmall cell lung cancer. Indian J Cancer. 2015;52: E168–171.
   PubMed Web of Science ®Google Scholar
• Chen X, Wei L, Zhao S. miR-338 inhibits the metastasis of lung cancer by targeting integrin β3. Oncol Rep. 2016;36:1467–1474.
   PubMed Web of Science ®Google Scholar
• Sun J, Feng X, Gao S, et al. microRNA-338-3p functions as a tumor suppressor in human nonsmallcell lung carcinoma and targets Ras-related protein 14. Mol Med Rep. 2015;11:1400–1406.
   PubMed Web of Science ®Google Scholar
• Luo J, Shi K, Yin SY, et al. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation. World J Surg Oncol. 2018;16:76.
   PubMed Web of Science ®Google Scholar
• Li J, Wang J, Chen Y, et al. A prognostic 4-gene expression signature for squamous cell lung carcinoma . J Cell Physiol. 2017;232:3702–3713.
   PubMed Web of Science ®Google Scholar
• Li Y, Gu J, Xu F, et al. Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data. Sci Rep. 2018;8:15834.
   PubMed Web of Science ®Google Scholar